Cash-strapped patient with diabetes who turn to low-cost “Walmart Insulins” could be putting their lives at risk, an expert warns.
The federal government has zealously guarded its authority over drug pricing.
His family thinks their son was rationing his insulin — using less than he needed — to try to make it last until he could afford to buy more.
Conservative nonprofits are funneling “dark money” — difficult-to-trace funds behind TV ads, phone calls, and other efforts used to influence politics.
Drug company promises to contain prices are a familiar — and fleeting. In past, their vows to restrain prices last only as long as it is politically necessary.